Andrew Tatarsky, Ph.D., Founder and Director The Center for Optimal Living will take us through a harm reduction approach which has compassion at its centre. This webinar looks at harm reduction across the range of risk behaviours...
Objective: In 2017, an academic health center in Chicago launched the multidisciplinary Substance Use Intervention Team (SUIT) to address opioid misuse across 18 inpatient units and in a new outpatient addiction medicine clinic. This report...
Substance use and misuse affect people worldwide, of all ages and from all walks of life, resulting in a substantial burden of ill health and mortality, and presenting big challenges in prevention and treatment.
PLOS Medicine is planning...
The objective of this two day training workshop "Screening, Brief Intervention, and Referral to Treatment (SBIRT)" was to train mental health professionals so that they could identify substance use problems, help their clients if they are...
Psychoactive substance use was regarded as a male affair in the past. However, recent findings show an increasing number of females are getting involved. We conducted a three year retrospective review of patients admitted to the Centre for...
Post traumatic stress disorder (PTSD) is a common co-ocuring disorder among patients with substance use disorders. Treatment of PTSD improves SUD treatment outcome. Many studies show that a large number of patients with co-morbid PTSD do...
El ácido γ-aminobutírico (GABA) es el principal neurotransmisor inhibitorio del sistema nervioso central (SNC) de los mamíferos y ejerce su acción a partir de la activación de tres receptores distintos. El receptor GABAB es una...
According to the World Drug Report opioids are the most harmful drug type, accounting for 70% of the adverse health impacts associated with drug use disorders worldwide. Treatment typically focusses on controlling withdrawal, preventing...
